首页> 外国专利> Antiviral interferon fixed to polysaccharide support - act on exterior of cells without effecting pathological processes inside cell

Antiviral interferon fixed to polysaccharide support - act on exterior of cells without effecting pathological processes inside cell

机译:固定在多糖支持物上的抗病毒干扰素-作用于细胞外部而不会影响细胞内部的病理过程

摘要

Interferon fixed to a support so that the interferon acts on the exterior of the cell without penetrating and effecting the pathological processing taking place within the cell is characterised in that the support is (a) a homopolysaccharide chosen from D-fructose polymers esp. laevosan (main link beta-2, 6-D-fructosyl-D-fructose), D-mannose polymers esp. mannan (main linkage: alpha-1,2, alpha-1,3 and alpha-1,6-D-mannosyl -D-mannose), D-galacturonate polymers esp. pectin (main linkage: alpha-1, 4-D-galacturonosyl-D-galacturonate), pentose polymers esp. xylan (main linkage : beta-1,4-D-xylosyl-D-xylose), D-galactose polymers esp. galactan (main linkage; beta-1,4-D-galactosyl-D-galactose) (b) a heteropolysaccharide containing modified sugars esp. powdered agarose (main linkage : beta-1,4-D-galactosyl-D-galactose), heteropolysaccharides containing substd. sugars esp. glycerol-pectate (main linkage : that of pectin) and derivatives containing more than one type of monosaccharide residue esp. heparin (main linkage alpha-1, 4-D-2-deoxy-2-sulphoamino-glucosyl-6-sulphate-D-Glucuronate) Antivval, treatment of certain forms of cancer and leukemia. When bonding in this way the interferon is not degraded by the cell and can be used in much smaller amounts. The supports are soluble or may be solubilised and the interferon may be administered by normal routes. The interferon is pref. fixed to a support activated by diazotisation esp. by the method of S.A. Barker et al (Immunology (72 23 689). Insoluble supports with fixed interferon may be solubilised by various treatments e.g. Sepharose (RTM) with fixed interferon may be hydrolysed by heating in an autoclave under 1 atmosphere and 110 degrees C for 39 mins at pH2.
机译:干扰素固定在支持物上,以使干扰素作用于细胞的外部而不会穿透并影响细胞内发生的病理过程,其特征在于支持物是(a)选自D-果糖聚合物esp的均多糖。 laevosan(主链接beta-2,6-D-果糖基-D-果糖),D-甘露糖聚合物,尤其是。甘露聚糖(主要键:α-1,2,α-1,3和α-1,6-D-甘露糖基-D-甘露糖),D-半乳糖醛酸酯聚合物,特别是。果胶(主要键:α-1,4-D-半乳糖醛糖基-D-半乳糖醛酸酯),戊糖聚合物,特别是。木聚糖(主键:β-1,4-D-木糖基-D-木糖),D-半乳糖聚合物,特别是。半乳聚糖(主键;β-1,4-D-半乳糖基-D-半乳糖)(b)含修饰糖的杂多糖,特别是。琼脂糖粉(主键:β-1,4-D-半乳糖基-D-半乳糖),杂多糖含有subdd。糖特别是甘油果胶(主要键:果胶)和含有一种以上单糖残基的衍生物。肝素(主要连接为α-1、4-D-2-脱氧-2-磺氨基-葡萄糖基-6-硫酸盐-D-葡萄糖醛酸)抗病毒,治疗某些形式的癌症和白血病。当以这种方式结合时,干扰素不会被细胞降解,可以以更小的量使用。载体是可溶的或可溶解的,并且干扰素可通过常规途径给药。干扰素是优选的。固定在由重氮化特别是激活的支持物上。通过SA Barker等人的方法(免疫学(72 23 689)。具有固定干扰素的不溶性支持物可通过多种处理溶解,例如,具有固定干扰素的Sepharose(RTM)可通过在1个大气压下于110摄氏度的高压釜中加热进行水解在pH2下放置39分钟。

著录项

  • 公开/公告号FR2279422B2

    专利类型

  • 公开/公告日1979-08-10

    原文格式PDF

  • 申请/专利权人 INSTITUT NAL SANTE RECHERCHE MED;

    申请/专利号FR19750021873

  • 发明设计人

    申请日1975-07-11

  • 分类号A61K45/02;

  • 国家 FR

  • 入库时间 2022-08-22 19:38:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号